isomethyleugenol has been researched along with Leukemia, Myelomonocytic, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akdag, R; Mufti, GJ; Ozbek, N; Stephenson, J | 1 |
Orkin, SH; Skalnik, DG; Strauss, EC | 1 |
2 other study(ies) available for isomethyleugenol and Leukemia, Myelomonocytic, Chronic
Article | Year |
---|---|
Methylation status within exon 3 of the c-myc gene as a prognostic marker in myeloma and leukaemia.
Topics: Acute Disease; Biomarkers, Tumor; Bone Marrow; Deoxyribonuclease HpaII; Deoxyribonucleases, Type II Site-Specific; DNA, Neoplasm; Exons; Genes, myc; Humans; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Methylation; Multiple Myeloma; Prognosis | 1993 |
CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; CCAAT-Enhancer-Binding Proteins; Cloning, Molecular; Cytochrome b Group; Deoxyribonuclease I; DNA; DNA-Binding Proteins; Gene Expression Regulation; Humans; Leukemia, Myelomonocytic, Chronic; Methylation; Molecular Sequence Data; Phagocytes; Promoter Regions, Genetic; Repressor Proteins; Sea Urchins; Tumor Cells, Cultured | 1991 |